Gaush Meditech Ltd (HKG:2407)

Market Cap	894.71M
Revenue (ttm)	1.52B
Net Income (ttm)	98.32M
Shares Out	146.67M
EPS (ttm)	0.67
PE Ratio	9.17
Forward PE	n/a
Dividend	0.30 (4.92%)
Ex-Dividend Date	Jun 23, 2025

Volume	28,400
Average Volume	63,900
Open	6.15
Previous Close	6.05
Day's Range	6.08 - 6.15
52-Week Range	4.80 - 16.12
Beta	-0.15
RSI	56.84
Earnings Date	Aug 22, 2025

About Gaush Meditech

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 884
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2407

Financial Performance

In 2024, Gaush Meditech's revenue was 1.43 billion, an increase of 1.58% compared to the previous year's 1.41 billion. Earnings were 92.39 million, a decrease of -46.75%.

Financial numbers in CNY